Live Breaking News & Updates on Ranipill Containing Ustekinumab Biosimilar

- Cash runway extended into 2025 - - Announced strategic program prioritization, expansion of manufacturing and plans to streamline business operations - . ....

United States , Talat Imran , Adalimumab Biosimilar , Ustekinumab Biosimilar , Rani Therapeutics Holdings Inc , Meeting Of The American Society For Bone , Exchange Commission , Strategic Program Prioritization , Term Growth Of The Ranipill Technology Platform , Mineral Research , Development Of Ranipill , Therapeutics Holdings , Chief Executive Officer , Subsequent Highlights , Streamline Business , Support Near Term Value Drivers , Long Term Growth , Ranipill Technology , Repeat Oral Administration , American Society , Ranipill Containing Ustekinumab Biosimilar , Successful Drug Delivery , High Capacity Pill , Delivered Orally , Awake Canines , Term Milestone Expectations ,